Coronavirus
Pfizer Requests FDA Authorization for Adult Booster Shots
Pfizer and BioNTech on Tuesday said they had asked the Food and Drug Administration (FDA) to authorize booster shots of their COVID-19 vaccine for all adults 18 and over, seeking to broaden who is eligible for a third shot.
The move comes as part of a long-running debate among experts over who should be eligible for booster shots. An FDA advisory panel voted against a request for all adults to have a booster in September, in what was a blow to the Biden administration’s earlier announcement of widespread shots.
But the eligibility has been gradually widening as experts point to concerns that the vaccines’ efficacy wanes over time.
